Europe Histopathology Services Market Insight (2021-2031)
The Europe histopathology services market size was valued at $6,882.53 million in 2021, and is expected to reach $12,921.23 million by 2031, registering a CAGR of 6.5% from 2021 to 2031. Histopathology is the diagnosis of diseases, and involves examining tissues or cells under microscope. Histopathology services technology can aid a research pipeline in two ways. The first one is that the specified file storage and viewing applications may be used to arrange macroscopic images, tissue microarrays, and entire slide images. The second application of histopathology services in research is the development and implementation of image analysis techniques. The full range of histopathology services includes necropsy techniques to sophisticated histological processing. Histopathology services includes wide variety of special stains and techniques, which includes immunohistochemistry and in situ hybridization.
Growth of the Europe histopathology services market is majorly driven by increase in prevalence of cancer; rise in the demand for accurate diagnostics, and development of new system by large number of key players. According to report published by Medscape, chronic diseases can be associated to the higher mortality rate. The main cause for the development of advanced diagnostic solutions is the rise prevalence of chronic disorders. Thus, the need for histopathology services increases, with the rise in the prevalence of chronic diseases. This drives the growth of the market.
Rise in geriatric population and rapid technological advancements in diagnostic systems are some of the factors that fuel the growth of the histopathology services market. According to the European Journal of Cancer in 2020, there were around 4 million new cases of cancer in Europe. The most common cancer is breast cancer and there were approximately 530,000 cases of breast cancer in women, and approximately 480,000 cases of lung cancer across the region. Therefore, surge in number of cancer cases can be attributed to rise in usage of histopathology services. This is anticipated to boost the growth of the Europe Histopathology Services Market.
Increase in the number of diagnostic testing and surge in demand for personalized medicine are the major factors that drive the growth of the market. Moreover, increase in prevalence of genetic disease significantly contributes toward the market growth, owing to the fact that histopathology services, are used for monitoring vital signs for early diagnosis and proper treatment of patients. Rise in demand for early diagnosis of disease for effective treatment acts a key driving force for the growth of the Europe Histopathology Services Market. Moreover, initiatives taken by governments for development of the diagnostic service center and increase in number of medical laboratories are the key factors that boost the growth of the market.
Technological advancement in histopathology services and surge in funding for various research activities and diagnostic testing propel the growth of the market. In addition, rise in demand for advanced tools for histopathology services in healthcare to enhance efficiency and surge in demand for personalized medicine fuel the market growth.
Furthermore, the initiative and funding activities by the European Commission Health Programme cancer project surge the need for histopathology services. The European Commissioner for Health and Food Safety funds $4 billion for beating cancer plan, which includes technological advancement, improve access to therapies, promote disease prevention, and early diagnosis testing. Increase in awareness among population regarding prevention and diagnosis of rare diseases augments the growth of the Europe histopathology services market.
What is the Impact of COVID-19 Pandemic on the Europe Histopathology Services Market?
The COVID-19 outbreak is anticipated to have a negative impact on the Europe histopathology services market. The number of elective treatments has reduced during the pandemic. Government has imposed restrictions and set guidelines to maintain social distancing among laboratory personnel needs. Moreover, to control the risk, all the unnecessary surgical treatments were postponed and closed all pathology centers globally, which hampered the Europe histopathology services market during pandemic.
Moreover, post-COVID-19 in 2021 the Europe Histopathology Services Market is registering pre-pandemic growth rate due to uplifting of restrictions and decrease in cases of COVID-19 that has resume all of the activities across the world. All the pathology laboratories and health related programs which is initiated by government and other private health centers are re-opened now. This is expected to drive the growth of the market during forecast period.
Histopathology Services Market Segmentation
The histopathology services market is segmented into type of examination, and country. On the basis of type of examination, the market is categorized into surgical specimen, gastrointestinal biopsy, breast biopsy, lung biopsy, biopsy of gynecological cancers, renal biopsy, pancreatic biopsy, skin tissue biopsy, liver biopsy, nerve biopsy, testicular biopsy, and others. On the basis of country, the market is analyzed across Germany, France, the UK, Italy, Spain, and Rest of Europe.
Segment Review
On the basis of type of examination, the surgical specimen segment dominated the market in 2021, and this trend is expected to continue during the forecast period, owing to increase in number of various types of surgical procedures, rise in demand for diagnosis of chronic diseases, and surge in adoption of diagnostic systems. However, the liver biopsy segment is expected to witness considerable growth during the forecast period, owing to increase in number of liver cancer cases and growth in number of key players for development of histopathology services systems in the healthcare industry.
By Type Of Examination
Surgical Speicimen segment holds a dominant position in 2021 and would continue to maintain the lead over the forecast period.
Germany dominated the histopathology services market in 2021, and is expected to continue to dominate during the forecast period, owing to rise in number of various types of cancer cases, presence of key players, development of the healthcare sector in the region. However, UK is expected to register the highest CAGR during 2021 to 2031, owing to increase in prevalence of chronic diseases, and development of healthcare infrastructure.
The key players that operate in the Europe histopathology services market include Acculabs Diagnostics UK Ltd, Cellular Pathology Services Limited, Great Ormond Street Hospital (GOSH) Laboratory, HCA Laboratories UK, Laboratoire Cerba, Sonic Healthcare Limited, Spire Healthcare Group Plc, Targos Molecular Pathology GmbH, TPL Path Labs, and Unilabs Group Services.
By Region
UK is expected to experience growth at the highest rate, registering a CAGR of 8.0% during the forecast period.
Key Benefits For Stakeholders
- The study provides an in-depth analysis of the Europe histopathology services market, and the current trends & future estimations to elucidate imminent investment pockets.
- It presents a quantitative analysis of the market from 2021 to 2031 to enable stakeholders to capitalize on the prevailing Europe Histopathology Services Market opportunities.
- Extensive analysis of the market based on procedures and services assists to understand the trends in the industry.
- Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the Europe Histopathology Services Market.
Europe Histopathology Services Market Report Highlights
| Aspects | Details |
 By Type |
|
 By Country |
|
 By Key Market Players |
|
Analyst Review
This section provides the opinions of the top level CXOs in the Europe histopathology services market. According to the CXOs, histopathology services are used for the microscopic examination of biological tissues for the diagnosis of infectious diseases. This can be done with the help of imaging techniques, in which the biopsy tissues can be obtained from inaccessible sites, such as pancreas.
As per the CXOs, the rise in number of collaborations and partnerships among government and private healthcare organizations, fuel the growth of the market. Viapath is a leading pathology service provider in the UK and in April 2021, it has partnered with Screo SYNLAB UK, NHS Foundation Trust and King’s College Hospital NHS Foundation. This partnership provides services to 1.7 million people who live in South London and this partnership aims to develop integrated pathology network. Thus, rise in number of histopathology services providers is expected to boost the growth of the histopathology services market in Europe.
The CXOs further added that surgical specimen segment is expected to remain dominant during the forecast period, owing to strong availability of this services provided by large number of key players in the market. Moreover, Germany is expected to offer lucrative opportunities to the market during the forecast period. However, the UK registered the fastest growth rate during the forecast period, owing to the surge in healthcare infrastructure, rise in disposable incomes, and well-established presence of domestic companies in the region.
The total market value of Europe Histopathology Services market is $6,882.53 million in 2021.
The forecast period for Europe Histopathology Services market is 2022 to 2031.
The market value of Europe Histopathology Services market in 2022 is $7,350.54 million.
The base year is 2021 in Europe Histopathology Services market
Top companies such as Acculabs Diagnostics UK Ltd, Sonic Healthcare Limited, Spire Healthcare Group Plc are some of the top companies in the Europe Histopathology Services market
Surgical Specimen segment dominated the global market in 2021, and expected to continue its dominance throughout the forecast period
Increase in number of surgical procedures, increasing prevalence of chronic diseases, advanced infrastructure for research & development and investments in healthcare is anticipated to drive the market in the forecast period.
Germany is projected to account for a major share of the Europe Histopathology Services market during the forecast period.
Histopathology is the diagnosis of diseases, and involves examining tissues or cells under microscope.
Histopathology Services are used for the diagnosis of various types of diseases such as cancer.
Loading Table Of Content...
